Culbertson A N & Co’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,165
| Closed | -$226K | – | 127 |
|
|
2024
Q3 | $226K | Hold |
1,165
| – | – | 0.04% | 124 |
|
|
2024
Q2 | $270K | Hold |
1,165
| – | – | 0.05% | 116 |
|
|
2024
Q1 | $251K | Hold |
1,165
| – | – | 0.04% | 117 |
|
|
2023
Q4 | $301K | Hold |
1,165
| – | – | 0.06% | 112 |
|
|
2023
Q3 | $299K | Hold |
1,165
| – | – | 0.06% | 111 |
|
|
2023
Q2 | $332K | Buy |
1,165
+345
| +42% | +$103K | 0.06% | 109 |
|
|
2023
Q1 | $228K | Hold |
820
| – | – | 0.05% | 115 |
|
|
2022
Q4 | $227K | Hold |
820
| – | – | 0.05% | 116 |
|
|
2022
Q3 | $218K | Buy |
+820
| New | +$174K | 0.05% | 114 |
|
|
2021
Q4 | – | Sell |
-820
| Closed | -$232K | – | 113 |
|
|
2021
Q3 | $232K | Hold |
820
| – | – | 0.05% | 109 |
|
|
2021
Q2 | $284K | Hold |
820
| – | – | 0.06% | 107 |
|
|
2021
Q1 | $229K | Hold |
820
| – | – | 0.05% | 109 |
|
|
2020
Q4 | $201K | Hold |
820
| – | – | 0.05% | 109 |
|
|
2020
Q3 | $233K | Hold |
820
| – | – | 0.06% | 106 |
|
|
2020
Q2 | $219K | Hold |
820
| – | – | 0.06% | 105 |
|
|
2020
Q1 | $259K | Hold |
820
| – | – | 0.08% | 100 |
|
|
2019
Q4 | $243K | Buy |
+820
| New | +$228K | 0.06% | 103 |
|
|
2019
Q1 | – | Sell |
-820
| Closed | -$247K | – | 105 |
|
|
2018
Q4 | $247K | Hold |
820
| – | – | 0.08% | 102 |
|
|
2018
Q3 | $290K | Hold |
820
| – | – | 0.08% | 104 |
|
|
2018
Q2 | $238K | Hold |
820
| – | – | 0.07% | 106 |
|
|
2018
Q1 | $225K | Hold |
820
| – | – | 0.07% | 102 |
|
|
2017
Q4 | $261K | Hold |
820
| – | – | 0.07% | 99 |
|
|
2017
Q3 | $257K | Hold |
820
| – | – | 0.08% | 93 |
|
|
2017
Q2 | $223K | Hold |
820
| – | – | 0.07% | 91 |
|
|
2017
Q1 | $224K | Hold |
820
| – | – | 0.07% | 90 |
|
|
2016
Q4 | $233K | Hold |
820
| – | – | 0.08% | 88 |
|
|
2016
Q3 | $257K | Buy |
+820
| New | +$243K | 0.09% | 81 |
|
|
2016
Q2 | – | Sell |
-1,100
| Closed | -$286K | – | 82 |
|
|
2016
Q1 | $286K | Hold |
1,100
| – | – | 0.11% | 75 |
|
|
2015
Q4 | $337K | Hold |
1,100
| – | – | 0.13% | 76 |
|
|
2015
Q3 | $321K | Sell |
1,100
-115
| -9% | -$38K | 0.14% | 77 |
|
|
2015
Q2 | $490K | Hold |
1,215
| – | – | 0.19% | 74 |
|
|
2015
Q1 | $513K | Sell |
1,215
-285
| -19% | -$112K | 0.2% | 72 |
|
|
2014
Q4 | $509K | Hold |
1,500
| – | – | 0.21% | 72 |
|
|
2014
Q3 | $496K | Hold |
1,500
| – | – | 0.21% | 72 |
|
|
2014
Q2 | $473K | Buy |
+1,500
| New | +$451K | 0.21% | 73 |
|
Other funds holding BIIB
Culbertson A N & Co's BIIB Position: Q4 2024 in Review
Culbertson A N & Co sold out of Biogen (BIIB) in Q4 2024, closing a stake of 1,165 shares — an estimated $226K sold.
Culbertson A N & Co first reported a position in BIIB in Q2 2014 and held it in 35 quarters. The position peaked at $513K in Q1 2015. 874 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.
- Culbertson A N & Co reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
- Culbertson A N & Co sold 1,165 Biogen shares in Q4 2024, an estimated $226K.
- Culbertson A N & Co first reported a position in Biogen in Q2 2014 and held it in 35 quarters.
- Culbertson A N & Co's Biogen position peaked at $513K in Q1 2015.
- 874 funds tracked by Wall St. Rank held Biogen as of Q4 2024.
Based on Culbertson A N & Co's 13F filing for Q4 2024, filed 16 Jan 2025.